Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals

Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Winc’s Initial Public Offering

Latham & Watkins represented Winc, Inc. in the offering. Manatt Represents Spartan Capital Securities LLC and Revere Securities LLC. Winc, Inc., one of the fastest growing at...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

GlobalFoundries’ Initial Public Offering

Cleary Gottlieb Steen & Hamilton represented GlobalFoundries in the offering, while Latham & Watkins represented the underwriters. GlobalFoundries® (GF®), a global leader in feature-rich semiconductor manufacturing, announced...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here